By regulating, either positively or negatively, target genes such as TGF-β, cyclin D1, c-jun, PTEN, p53 and p21, EGR-1 decreases cell proliferation, carrying out tumor suppressive functions in several tumor types including gliomas [10,11]. This evidence concerns the gene EGR1 and central nervous system cancer.